CXCR7 GPCR insurmountable antagonist

target engagement in rodent, 61% F in dog

from 300k HTS vs. _-arrestin recruitment, opt.

J. Med. Chem., Dec. 14, 2020

Idorsia Pharma (Actelion), Allschwil, CH

Chemical structure of molecule ACT-1004-1239

Idorsia/Actelion CXCR7 GPCR insurmountable antagonist


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: